1. Home
  2. TMDX vs APPN Comparison

TMDX vs APPN Comparison

Compare TMDX & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TMDX
  • APPN
  • Stock Information
  • Founded
  • TMDX 1998
  • APPN 1999
  • Country
  • TMDX United States
  • APPN United States
  • Employees
  • TMDX N/A
  • APPN N/A
  • Industry
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • APPN Computer Software: Prepackaged Software
  • Sector
  • TMDX Health Care
  • APPN Technology
  • Exchange
  • TMDX Nasdaq
  • APPN Nasdaq
  • Market Cap
  • TMDX 2.3B
  • APPN 2.3B
  • IPO Year
  • TMDX 2019
  • APPN 2017
  • Fundamental
  • Price
  • TMDX $111.50
  • APPN $31.69
  • Analyst Decision
  • TMDX Buy
  • APPN Hold
  • Analyst Count
  • TMDX 10
  • APPN 8
  • Target Price
  • TMDX $122.89
  • APPN $35.33
  • AVG Volume (30 Days)
  • TMDX 1.2M
  • APPN 587.2K
  • Earning Date
  • TMDX 05-08-2025
  • APPN 05-08-2025
  • Dividend Yield
  • TMDX N/A
  • APPN N/A
  • EPS Growth
  • TMDX N/A
  • APPN N/A
  • EPS
  • TMDX 1.41
  • APPN N/A
  • Revenue
  • TMDX $488,227,000.00
  • APPN $633,613,000.00
  • Revenue This Year
  • TMDX $25.33
  • APPN $12.27
  • Revenue Next Year
  • TMDX $20.53
  • APPN $10.15
  • P/E Ratio
  • TMDX $79.36
  • APPN N/A
  • Revenue Growth
  • TMDX 64.43
  • APPN 13.15
  • 52 Week Low
  • TMDX $55.00
  • APPN $24.00
  • 52 Week High
  • TMDX $177.37
  • APPN $43.33
  • Technical
  • Relative Strength Index (RSI)
  • TMDX 78.52
  • APPN 60.19
  • Support Level
  • TMDX $92.49
  • APPN $29.97
  • Resistance Level
  • TMDX $95.71
  • APPN $33.43
  • Average True Range (ATR)
  • TMDX 4.79
  • APPN 1.14
  • MACD
  • TMDX 0.81
  • APPN 0.29
  • Stochastic Oscillator
  • TMDX 71.36
  • APPN 78.06

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: